Joyce LaViscount

2018

In 2018, Joyce LaViscount earned a total compensation of $1.1M as Chief Financial Officer and Chief Operating Officer at HELIUS MEDICAL TECHNOLOGIES, a 18% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$138,432
Option Awards$607,425
Salary$342,720
Other$8,234
Total$1,096,811

LaViscount received $607.4K in option awards, accounting for 55% of the total pay in 2018.

LaViscount also received $138.4K in non-equity incentive plan, $342.7K in salary and $8.2K in other compensation.

Rankings

In 2018, Joyce LaViscount's compensation ranked 8,750th out of 14,244 executives tracked by ExecPay. In other words, LaViscount earned more than 38.6% of executives.

ClassificationRankingPercentile
All
8,750
out of 14,244
39th
Division
Manufacturing
3,490
out of 5,765
40th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
448
out of 849
47th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
265
out of 547
52nd
Industry
Electromedical and Electrotherapeutic Apparatus
37
out of 77
52nd
Source: SEC filing on April 26, 2019.

LaViscount's colleagues

We found two more compensation records of executives who worked with Joyce LaViscount at HELIUS MEDICAL TECHNOLOGIES in 2018.

2018

Philippe Deschamps

HELIUS MEDICAL TECHNOLOGIES

Chief Executive Officer

2018

Jennifer Laux

HELIUS MEDICAL TECHNOLOGIES

Chief Commercialization Officer

News

In-depth

You may also like